Gabapentin: Pharmacology and its use in pain management

Anaesthesia

Volumn 57, Issue 5, 2002, Pages 451-462

  Rose, M A ^a   Kam, P C A ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Pain: neuropathic; Pharmacology: gabapentin

Indexed keywords

6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; ANTACID AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CALCIUM CHANNEL; CARBAMAZEPINE; CIMETIDINE; GABAPENTIN; LAMOTRIGINE; MORPHINE; NALOXONE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYTOIN; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ALLODYNIA; ANALGESIC ACTIVITY; ASTHENIA; ATAXIA; CLINICAL TRIAL; COMPLEX REGIONAL PAIN SYNDROME; CONVULSION; DIABETIC NEUROPATHY; DISEASE MODEL; DOSE RESPONSE; DRUG ABSORPTION; DRUG ANTAGONISM; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG STRUCTURE; ERYTHROMELALGIA; FATIGUE; GERIATRICS; HEADACHE; HUMAN; HYPERALGESIA; MULTIPLE SCLEROSIS; NEURALGIA; NONHUMAN; PAIN; PHYSICAL CHEMISTRY; POSTHERPETIC NEURALGIA; POSTPOLIOMYELITIS SYNDROME; REVIEW; SEIZURE; SOMNOLENCE; SPINAL CORD DORSAL HORN; SPINAL CORD INJURY; STRUCTURE ANALYSIS; TERATOGENICITY; TRIGEMINUS NEURALGIA; VERTIGO;

ACETIC ACIDS; AMINES; ANALGESICS; ANTICONVULSANTS; CYCLOHEXANECARBOXYLIC ACIDS; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; NERVOUS SYSTEM DISEASES; PAIN; PILOT PROJECTS; PREGNANCY; RANDOMIZED CONTROLLED TRIALS;

EID: 0036252330     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0003-2409.2001.02399.x     Document Type: Review

References (131)

1. Mechanisms of action of new antiepileptic drugs
2. Antiepileptics from gamma-aminobutyric acid
3. Gabapentin
4. Determination of gabapentin in plasma and urine by capillary column gas chromatography
5. Determination of gabapentin in plasma and urine by high-performance liquid chromatography and precolumn labeling for ultraviolet detection
6. A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma
7. Pharmacokinetic model and absolute bioavailability of the new anticonvulsant gabapentin
8. Dose-linearity of the new anticonvulsant gabapentin after multiple oral doses
9. Clinical pharmacokinetics of gabapentin
10. Lack of a pharmacokinetic interaction between phenobarbitone and gabapentin
11. Pharmacokinetics and metabolism of gabapentin in rat, dog and man
12. Selected CSF biochemistry and gabapentin concentrations in the CSF and plasma in patients with partial seizures after a single oral dose of gabapentin
13. Gabapentin concentrations in human brain
14. Gabapentin pharmacokinetics in patients with various degrees of renal function
15. Potential antiepileptic drugs: Gabapentin
16. Drug interaction study of the new anticonvulsant gabapentin with phenytoin in epileptic patients
17. Pharmacokinetics of gabapentin in patients treated with phenytoin
18. Disposition of gabapentin in anuric subjects on hemodialysis
19. Effect of Maalox TC on single-dose pharmacokinetics of gabapentin capsules in healthy subjects
20. 3H]gabapentin to a novel site in rat brain: Autoradiographic studies
21. Gabapentin anticonvulsant action in rats: Disequilibrium with peak drug concentrations in serum and brain microdialysate
22. 3H]-gabapentin binding to a novel site in rat brain: Homogenate binding studies
23. Potent and stereospecific anticonvulsant activity of 3-isobutyl GABA relates to in vitro binding at a novel site labelled by tritiated gabapentin
24. Gabapentin increases aminooxyacetic acid induced GABA accumulation in several regions of rat brain
25. The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy
26. Inhibition by GABA, baclofen and gabapentin of dopamine release from rabbit caudate nucleus. Are there common or different sites of action?
27. Gabapentin decreases monoamine release without affecting acetylcholine release in the brain
28. Limitation by gabapentin of high frequency action potential firing by mouse central neurons in cell culture
29. The anti-allodynic effects of amitryptyline, gabapentin and lidocaine in a rat model of neuropathic pain
30. Gabapentin suppresses ectopic nerve discharges and reverses allodynia in neuropathic rats
31. Gabapentin (neurontin) and S-(+)-3-isobutyl GABA represent a novel class of selective antihyperalgesic agents
32. Effect of subarachnoid gabapentin on tactile-evoked allodynia in a surgically-induced neuropathic pain model in the rat
33. Characterization of the effects of gabapentin and 3-isobutyl-(aminobutyric acid) on substance-P induced thermal hyperalgesia
34. The effect of intrathecal gabapentin on pain behaviour and hemodynamics on the formalin test in the rat
35. Gabapentin inhibits excitatory synaptic transmission in the hyperalgesic spinal cord
36. The effect of intrathecal gabapentin a 3-isobutyl gamma-aminobutyric acid on the hyperagesia observed after after thermal injury in the rat
37. Attenuation of formalin-induced nociceptive behaviours following local peripheral injection of gabapentin
38. A summary of mechanistic hypotheses of gabapentin
39. Gabapentin actions on ligand- and voltage-gated responses in cultures rodent neurons
40. Excitatory amino acid receptors in epilepsy
41. Voltage-sensitive calcium channels in spinal nociceptive processing. Blockade of N and P type channels inhibits formalin-induced nociception
42. Evaluation of gabapentin and S-(+)-3-isobutylgaba in a rat model of postoperative pain
43. Systemic gabapentin and S(+)-3-isobutyl-gamma-aminobutyric acid block secondary hyperalgesia
44. Gabapentin and pregabolin, but not morphine and amitryptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat
45. Inhibition of neuronal Ca(2+) influx by gabapentin and subsequent reduction of neurotransmitter release from rat neocortical slices
46. Inhibition of K(+)-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin
47. Gabapentin toxicity
48. Safety and tolerability of gabapentin as adjunctive therapy in a large, multicenter study
49. Lack of serious toxicity following gabapentin overdose
50. A case of sustained massive gabapentin overdose without serious side effects
51. Reversible acute renal allograft dysfunction due to gabapentin
52. Stevens-Johnson syndrome associated with gabapentin
53. Gabapentin may be hazardous in myasthenia gravis
54. Gabapentin in childhood epilepsy. A prospective evaluation of efficacy and safety
55. Gabapentin as add-on therapy for refractory partial epilepsy: Results of five placebo-controlled trials
56. Monotherapy trials with gabapentin for partial epilepsy
57. Cognitive abilities and adjustment with gabapentin: Results of a multisite study
58. Evaluation of encephalotropic and psychotropic properties of gabapentin in man pharmaco-EEG and psychometry
59. Gabapentin
60. use of gabapentin in the treatment of neuropathic pain
61. Gabapentin prevents hyperalgesia during the formalin test in diabetic rats
62. Evaluation of interaction between gabapentin and ibuprofen on the formalin test in rats
63. Synergistic effect between intrathecal non-NMDA antagonist and gabapentin on allodynia induced by spinal nerve ligation in rats
64. The effect of gabapentin on neuropathic pain
65. Effects of gabapentin on the different components of peripheral and central neuropathic pain syndromes: A pilot study
66. Experience with gabapentin for neuropathic pain in the head and neck. Report of ten cases
67. Case report on gabapentin
68. Neuropathic pain after anti-HIV gene therapy successfully treated with gabapentin
69. Treatment of central pain with gabapentin: Case reports
70. Using gabapentin to treat neuropathic pain
71. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial
72. Anticonvulsant drugs for acute and chronic pain
73. Gabapentin therapy for diabetic neuropathic pain
74. Randomised double-blind study comparing the efficacy of gabapentin with amitryptyline on diabetic peripheral neuropathy pain
75. Gabapentin vs. amitryptyline in painful diabetic neuropathy. An open-label pilot study
76. Gabapentin for the treatment of post-herpetic neuralgia: A randomized controlled trial
77. Gabapentin as an adjuvant to opioid analgesia for neuropathic cancer pain
78. Gabapentin in trigeminal neuralgia
79. Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients
80. Low-dose gabapentin combined with either lamotrigine or carbemazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis
81. Acute and chronic pain syndromes in multiple sclerosis
82. Gabapentin effect on spasticity in multiple sclerosis
83. Gabapentin for relief of upper motor neuron symptoms in multiple sclerosis
84. Open label treatment for pain in multiple sclerosis
85. An open label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients
86. Gabapentin is effective in treating nocturnal painful spasms in multiple sclerosis
87. Reflex sympathetic dystrophy treated with gabapentin
88. Reflex sympathetic dystrophy
89. Gabapentin in the management of reflex sympathetic dystrophy
90. Use of gabapentin in the treatment of childhood reflex sympathetic dystrophy
91. Gabapentin in the prophylaxis of migraine: A double-blind randomized placebo-controlled study
92. SUNCT syndrome responsive to gabapentin
93. Chronic cluster headache responding to gabapentin: A case report
94. Function limiting dysesthetic pain syndrome among traumatic SCI patients: A cross sectional study
95. Gabapentin in spinal cord injury pain
96. A case of spinal cord injury-related pain with baseline rCBF brain SPECT imaging and beneficial response to gabapentin
97. Gabapentin for chronic pain in spinal cord injury: A case report
98. Effectiveness of gabapentin in controlling spasticity: A quantitative study
99. Gabapentin for treatment of spasticity in patients with spinal cord injury
100. Gabapentin in the treatment of distal symmetric axonopathy in HIV infected patients
101. HIV neuropathy treated with gabapentin
102. Erythermalgia (erythromelalgia) of the extremities: A syndrome characterized by redness, heat and pain
103. Erythromelalgia pain managed with gabapentin
104. Postpoliomyelitis pain treated with gabapentin
105. Interstitial cystitis and the potential role of gabapentin
106. Gabapentin treatment for muscle cramps: An open-label trial
107. Use of gabapentin to treat taxane-induced myalgias
108. Gabapentin as treatment for hemifacial spasm
109. Gabapentin therapy for vulvodynia
110. Relief of anesthesia dolorosa with gabapentin
111. Gabapentin for the treatment of dysesthetic pain after reconstructive surgery
112. A case report of reduction in alcohol craving and protection against alcohol withdrawal by gabapentin
113. Treatment of alcohol withdrawal syndrome with gabapentin
114. Gabapentin: A review of published experience in the treatment of bipolar disorder and other psychiatric conditions
115. Clinical experience with gabapentin in patients with bipolar of schizoaffective disorder: Results of an open-label study
116. Gabapentin and lamotrigine in bipolar disorder
117. Open maintenance treatment of bipolar disorder spectrum patients who responded to gabapentin augmentation in the acute phase of treatment
118. Gabapentin as adjunct to standard mood stabilizers in outpatients with mixed bipolar symptomatology
119. Clinical experience using adjunctive gabapentin in treatment-resistant bipolar mixed states
120. Gabapentin treatment for post-traumatic stress disorder
121. Effectiveness of gabapentin for the treatment of behavioral disorders in dementia
122. Treatment of dementia-associated agitation with gabapentin
123. Combination of donepezil and gabapentin for behavioral disorders in Alzheimer's disease
124. Gabapentin for self-injurious behaviour in Lesch-Nyhan syndrome
125. A randomized placebo controlled comparative trial of gabapentin and propranolol in essential tremor
126. Treatment of 'restless legs syndrome' with gabapentin
127. Gabapentin treatment for brachioradial pruritis
128. Gabapentin treatment in a child with delayed-onset hemichorea/hemiballismus
129. Anti-depressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: A quantitative systematic review
130. Anticonvulsant drugs for management of chronic pain: A systematic review
131. A systematic review of antidepressants in neuropathic pain